This present investigation is related with metered dose inhalation formulations and manufacturing process. The active pharmaceutical ingredient can be beta-2 agonists, corticosteroids, or combined of them. The inhalation formulations are homogenized suspension with hydrofluoroalkane propellant, and minimal amount of ethanol and polyetheleneglycol as suspending and particle size modifying agents.